IL11 and breast carcinoma: Furthermore, a recent study using a breast cancer cell line (MDA-MB-468) xenograft model showed that IL11 expressing sub-clone populations in heterogeneous tumours acted in a non-cell autonomous manner, causing non IL11-expressing cells to behave in the same manner to drive proliferation and tumour growth [46].